Search results for Biorestorative Therapies

BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Imp...

BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Imp...

Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least…

Regenerative Medicine: Promise, Hype, and What Actually Works

Regenerative therapy is any treatment therapy that improves tissue health or function. With that definition, we can include platelet-rich plasma (PRP), stem cells, and autologous c...

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

If approved, ReNu® will revolutionize treatment options for millions of patients with knee OA pain CANTON, Mass., April…

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

Developing a Drug To Reverse Heart Disease

We have spoken with Reason from Repair Biotechnologies about his company’s lead candidate, REP-0004, a drug targeting the liver to reduce excess intracellular free cholesterol. The...

Combining Botox with Advanced Wellness Treatments

Theragen Receives First European Patent for ActaStimВ®-S

Dr. Ran Rubinstein Introduces Renuva(R): A Breakthrough Non-Surgical Fat Restoration Treatment in New York and New Jerse...

Double board-certified facial plastic surgeon now offers Renuva at Laser & Cosmetic Surgery Specialists in Newburgh, NY and Rubinstein Plastic Surgery Center in Montvale, NJ

Atreon Orthopedics® and RenovoDerm® Announce Merger

Positions Synthetic Portfolio as a Leading Solution for Tissue Repair and Remodeling in Substantial Markets Enables Autobiologic™ Platform…

Revolution Medicines

Revolution Medicines Anonymous (not verified) Tue, 05/05/2026 - 02:20 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...

[Extra! Extra!] Beyond Adrenal Fatigue: Implantable Cell Therapy

Though not recognized by the medical field, many in the natural health field see individuals appearing to struggle with adrenal fatigue or slow adrenal functioning. The medical fie...

First Human Data for Rubedo Life Sciences' Senolytic Drug RLS-1496

New senolytic drugs to clear the accumulation of senescent cells in aged tissues are working their way into clinical trials at the usual slow pace for medical development, slowed e...

No Waiting Room. No Beverly Hills Price Tag. California Trim Clinic Is Shipping Physician-Prescribed Longevity Peptides...

California Trim Clinic is expanding nationwide access to physician-prescribed compounded peptide therapy at a time when longevity medicine is no longer limited to elite concierge c...

Life Bio’s Trial: Is the FDA Warming to Rejuvenation?

The FDA views aging as an inevitability, not a medical target. However, with Life Biosciences moving the first cellular reprogramming therapy into human trials this year, things mi...

restor3d Announces Full Commercial Release of the Aeros™ Modular Stem System

Bioretec Ltd’s business review Q1 2026: Early Traction from Renewed Strategy

Bioretec Ltd summaries its 1Q26 revenue and strategy. The post Bioretec Ltd’s business review Q1 2026: Early Traction from Renewed Stra...

Atreon and RenovoDerm Put Tendons and Wounds Under One Synthetic Roof

Two rapidly growing synthetic biomaterials platforms, Atreon Orthopedics and RenovoDerm, have merged and the synergies are clear.

HexemBio raises $10.4M for a stem cell rejuvenation therapy

The Berkeley biotech is backing a Nature-published approach that recreates the embryonic environment where blood stem cells first form, rather than reprogramming aged cells chemica...

The Emerging Science Behind NAD IV Therapy

In recent years, interest in advanced wellness treatments has expanded beyond traditional supplements and lifestyle changes. One of the most talked-about therapies in regenerative...

An Update on Progress at Repair Biotechnologies, Developing Means to Regress Atherosclerotic Plaque

Atherosclerosis is the development of fatty plaques that narrow blood vessels and eventually rupture to cause a stroke or heart attack, the most common cause of human mortality. At...

Restore Vision Secures ¥1.3 Billion in Pre-Series B Funding to Accelerate Global Development of Gene Therapy for Retinal...

Restore Vision, a company developing gene therapy drugs to regenerate vision lost due to retinal diseases, announced on the 15th that it has raised ¥1.3 billion in a Pre-Series B r...

Atreon OrthopedicsВ® and RenovoDermВ® Announce Merger

‘Wolverine in a Vial’? Patients Are Flooding Search Results With Questions About BPC-157 and TB-500 — California Trim Cl...

As online interest in BPC-157 continues to climb, California Trim Clinic is addressing the surge in patient questions surrounding the peptide's potential role in recovery, repair,...